HCW Biologics Inc.

NASDAQ: HCWB · Real-Time Price · USD
4.15
-0.19 (-4.38%)
At close: Aug 15, 2025, 3:48 PM
4.33
-0.69%
Pre-market: Aug 15, 2025, 09:28 AM EDT

HCW Biologics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.57M 2.84M 6.72M n/a
Cost of Revenue
1.61M 2.28M 4.14M 543.6K
Gross Profit
959.4K 560.36K 2.59M -543.6K
Operating Income
-29.48M -25.72M -15.08M -13.37M
Interest Income
n/a n/a n/a 505.37K
Pretax Income
-30.02M -24.99M -14.9M -12.86M
Net Income
-30.02M -24.99M -14.72M -12.36M
Selling & General & Admin
6.03M 13.44M 8.33M 4.98M
Research & Development
6.39M 7.68M 9.34M 8.17M
Other Expenses
18.02M 5.52M n/a 218.47K
Operating Expenses
28.83M 21.03M 17.67M 13.37M
Interest Expense
1.16M 283.04K 126.66K n/a
Selling & Marketing Expenses
-804.86K 245.61K n/a n/a
Cost & Expenses
30.44M 28.56M 21.8M 13.37M
Income Tax Expense
n/a n/a -178.07K -505.37K
Shares Outstanding (Basic)
38.79M 35.93M 35.82M 35.77M
Shares Outstanding (Diluted)
38.79M 35.93M 35.82M 35.77M
EPS (Basic)
-0.77 -0.7 -0.41 -0.35
EPS (Diluted)
-0.77 -0.7 -0.41 -0.35
EBITDA
-27.68M -23.58M -14.18M -12.82M
EBIT
-28.87M -24.71M -14.77M -13.37M
Depreciation & Amortization
1.18M 1.14M 589.61K 543.6K